Post-transcriptional regulatory mechanisms play a role in many biological contexts through the control of mRNA degradation, translation and localization. Here, we show that the uncharacterized RING finger protein RNF219 co-purifies and strongly associates with the CCR4-NOT complex, the major mRNA deadenylase in eukaryotes, that mediates translational repression in a deadenylase activity-dependent and -independent manner. Strikingly, although RNF219, inhibits the deadenylase activity of CCR4-NOT, it enhances its capacity to repress translation of a targeted mRNA, an effect of RNF219 that requires its interaction with CCR4-NOT. We propose that RNF219 is an interacting partner of the CCR4-NOT complex that switches the translational repressive activity of CCR4-NOT from a deadenylation-dependent to a deadenylation-independent mechanism. CCR4-NOT is recruited by RNA binding proteins (RBPs) or miRNAs to specific 3' untranslated regions (UTRs) in mRNAs under certain physiological conditions 16-21 , or during developmental processes 22,23 Besides its role in deadenylation-dependent mRNA decay, CCR4-NOT can regulate translation in a deadenylation-indeendent manner. In this pathway, the translation repressors DDX6 (p54/RCK) (yeast ortholog: Dhh1) and EIF4ENIF1 (4E-T) bind to the CCR4-NOT scaffold subunit CNOT1 24,25 . These proteins can activate the decapping machinery, which leads to translation inhibition, mRNA storage and/or mRNA degradation [26][27][28][29] .Here, we identify the heretofore uncharacterized C3HC4 RING domain dependent E3 Ubiquitin ligase RNF219, which stably binds the CCR4-NOT complex. We further show that RNF219 inhibits the expression and stabilizes the poly(A) tail of a targeted mRNA. Moreover, loss of RNF219 interaction with CCR4-NOT greatly abolishes these two activities.Hence, we propose that RNF219 may act as a molecular switch that enables CCR4-NOT to change function from deadenylation to deadenylation-independent translational repression.
MATERIAL AND METHODS
Cell cultureHEK293T, HeLa, and U2OS cells were grown in DMEM (Life Technologies) containing 10% FBS (Sigma-Aldrich) and 1% penicillin/streptomycin (Life Technologies). HEK293T and HeLa RNF219 CRISPR KO (HEK293T SG1-C and HeLa SG1-C) construct and cell lines were generated using Ran et al. published protocol 30 . The sequences used to generate the guide RNA are sgRNA_1F (CACCGCTATGCTAAGCCATACGGTC), sgRNA_1R (AAACGACCGTATGGCTTAGCATAG).
Antibodies and reagentsAntibodies were obtained from Santa Cruz Biotechnology (Tubulin sc-5286, RPL3 sc-86828, p27 Antibody (F-8) sc-1641), Bethyl Laboratories (CNOT3 A302-156A, CNOT2 A302-562A, RNF219 A302-540A (RNF219-C)), Proteintech (CNOT1 14276-1-AP), Covance (anti-HA.11, MMS-101P) and Abcam (GAPDH ab9485). FLAG-M2 agarose (F2426 or A2220-5ML) and FLAG peptide (F3290-4MG) were purchased from Sigma-Aldrich. RNF219 specific antibodies were produced using an internal (RNF219-A) or C-terminal (RNF219-B) peptide by Abnova (Taiwan). Secondary antibodies were purchased from Cell Signaling Technology (goat anti...